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Progress Toward the Eradication of
Dracunculiasis (Guinea Worm Disease): 1994
Dracunculiasis, or guinea worm disease (GWD),
is a disabling infection caused by the nematode
parasite Dracunculus medinensis. The disease is
endemic in India, Africa, and the Middle East. Peo-
ple become infected when they drink water contain-
ing tiny crustaceans, called copepods or “water
fleas,” that act as intermediate hosts of the organism
and harbor infective larvae. When the ingested co-
pepods are killed by the digestive juices in the stom-
ach, the larvae are released and move to the small
intestine. They penetrate the intestinal wall and
migrate to the connective tissues of the thorax,
where male and female larvae mature and mate 60
to 90 days after infection. Over the next year, female
worms grow to maturity, reach a length of 70 cm or
more (2–3 feet), and slowly migrate to the surface of
the body. Worms emerge from the lower extremities
in about 90% of cases, but they can also appear in
the upper extremities, the trunk, buttocks, genita-
lia, or other parts of the body.
Infected persons remain asymptomatic for ap-
proximately a year after infection when the mature
female worm approaches the skin and forms a pain-
ful papule in the dermis. This papule can become a
blister within 24 hours or may enlarge for several
days before becoming a blister. Eventually it rup-
tures, exposing the worm. Shortly before the skin
lesion forms, pronounced systemic symptoms may
occur, including erythema and urticarial rash with
intense pruritus, nausea, vomiting, diarrhea, and
dizziness. On contact with fresh water, a loop of the
worm’s uterus opens and discharges a swarm of
motile larvae. This process may be repeated, if the
lesion is resubmerged in water, until the entire brood
of larvae is discharged. Larvae ingested by copepods
mature in the body cavity of the intermediate host
in about 2 weeks. Stagnant sources of drinking
water such as ponds, cisterns, pools in dried-up river
beds, temporary hand-dug wells, and  step-wells
commonly harbor populations of freshwater cope-
pods and are the usual sites where the infection is
transmitted.
As the worm emerges through the skin lesion, the
affected person pulls it out slowly and carefully,
usually by winding a few centimeters each day on a
stick. This very painful process may last many
weeks. Pain and other symptoms may lessen with
the rupture of the blister, but at this time pyogenic
organisms often invade the superficial lesion and
worm tract and aggravate the condition. If the worm
breaks during traction, an intense inflammatory
reaction occurs, with pain, swelling, and cellulitis
along the worm track. Infected persons are often
incapacitated for several weeks, or for months, if
complications caused by secondary bacterial infec-
tions ensue.
Infected persons do not develop immunity, and
there is no cure for GWD. Pain from emerging worms
may be relieved by applying wet compresses to the
lesion or by immersing the lesion in a container of
water, and then safely disposing of the released
larvae. Placing an occlusive bandage on the wound
to keep it clean prevents the patient from contami-
nating sources of drinking water. Once the worm
appears, oral medications to relieve the associated
pain and topical antiseptics or antibiotic ointment
to minimize the risk for secondary infections allows
the worm to be removed by gentle traction over a
number of days.
The World Health Organization (WHO) has tar-
geted GWD for eradication by the end of 1995. A
coalition of agencies, institutions, and organizations
are providing technical and financial assistance to
national eradication programs.
An understanding of the factors that contribute
to the emergence of dracunculiasis provides the ba-
sis for the current elimination program. GWD can
be eradicated for several reasons: 1) there is no
human carrier beyond the 1-year incubation period;
2) there is no known animal reservoir; 3) detection
of patent infections (i.e., worms protruding from skin
lesions) is an easy way to assess the presence of the
disease in communities, and protrusion of the worm
is required for transmission; 4) transmission of the
disease is markedly seasonal, facilitating the timing
and effectiveness of surveillance and control inter-
ventions, including containment of cases; 5) the
methods for controlling transmission are simple,
and 6) the disease is well recognized by the local
population in areas where it is endemic.
The overall strategy of national GWD eradication
programs includes three operational phases: l) con-
ducting baseline surveys to identify villages where
the disease is endemic; 2) training village-based
health workers to use case registries for monthly
surveillance and to implement control interventions
in affected communities; and 3) using case-contain-
ment, i.e., prompt detection of all remaining cases
(before or within 24 hours of worm emergence),
treatment of the lesions to prevent transmission,
and close supervision of village-based health work-
ers to ensure that each case has been properly con-
tained (1).
The thrust of control interventions is to educate
affected persons about the origin of the disease and
about the measures they and their communities can
take to prevent it. Affected households are provided
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to remove the copepods from water. Household mem-
bers are also taught that those with emerging
worms should be kept from entering sources of
drinking water. Other control interventions include
providing safe drinking water to affected villages
and selectively using the insecticide temefos to re-
duce copepod populations.
In 1986, an estimated 3.32 million cases of GWD
occurred in Africa (2). That same year, only 22,610
cases of GWD were reported from India, the only
affected country with a national eradication cam-
paign then underway. Worldwide cases reported to
WHO have declined from 781,219 in 1988 to 221,055
in 1993 (3). By 1990, 9 of the 19 affected countries
had initiated eradication programs and had con-
ducted baseline surveys to assess the extent of GWD
(Figure 1, Table 1). At the end of 1994, all 19 coun-
tries were actively combating the diseases, and the
provisional number of cases reported to WHO was
164,750 (Figure 2, Table 2). The number of affected
villages was reduced from more than 23,000 in 1993
to fewer than 10,000; 52% of the affected villages
were in the case-containment phase.
In 1994, Pakistan had no cases (4). (Pakistan is
the first country where GWD was endemic during
the 1980s to have eliminated indigenous transmis-
sion of the disease for 1 year.) Yemen reported small
foci of disease transmission for the first time in
several years, and Sudan reported 28,899 GWD
cases during active village-based searches, and
through its passive surveillance system (5). In early
March 1995, Sudan revised the number of cases
reported to WHO for 1994 to 53,092 cases. Although
Figure 1. Status of dracunculiasis eradication in Africa:
1990.
Figure 2. Status of dracunculiasis eradication in Africa:
1994.
Table 1. Dracunculiasis cases reported, 1990*
Country Number of cases
Nigeria 394,082
Ghana 117,034
Burkina Faso 42,187
Benin 37,414
Mauritania 8,036
India 4,798
Togo 3,042
Cameroon 742
Pakistan 160
Chad† –
Côte d’Ivoire† –
Ethiopia† –
Kenya† –
Mali† –
Niger† –
Senegal† –
Sudan† –
Uganda† –
Yemen† –
*Cases reported to the World Health organization from coun-
tries completing national case searches or from active vil-
lage-based surveillance.
† No information available at this time.
Table 2. Dracunculiasis cases reported, 1994*
Country Number of cases
Sudan 53,092
Nigeria 39,774
Niger 23,568
Uganda 10,409
Ghana 8,432
Burkina Faso 6,859
Mali 5,396
Togo 5,045
Mauritania 5,029
Côte d’Ivoire 4,700
Benin 3,440
Ethiopia 1,252
Chad 640
India 371
Senegal 186
Yemen 74
Kenya 37
Cameroon 30
Pakistan 0
*Provisional data reported to the World Health Organization
from countries completing national case searches or from
active village-based surveillance. Sudan’s report to WHO
includes cases reported by the Passive Surveillance System.
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precise, their relative magnitude likely reflects that
the incidence of disease there exceeds that reported
by any of the other affected countries.
The global GWD eradication campaign faces two
major challenges in 1995: to complete implementa-
tion of the case-containment strategy and other con-
trol interventions, such as insecticide use, in villages
of all affected countries and to mobilize greater pub-
lic support in these countries. The countries that
pose the greatest eradication challenge are Sudan,
Niger, and Nigeria. However, even in the countries
with the fewest cases, markedly tighter control
measures will be required to completely interrupt
transmission of GWD by the end of 1995. Success of
the eradication campaign depends on continued
funding and on the ability of national programs and
collaborating agencies and organizations to com-
plete the needed surveillance and control interven-
tions.
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